Genomic Valley Biotech
28.73
-1.51(-4.99%)
Market Cap₹8.74 Cr
PE Ratio432.00
IndustryHealthcare
Company Performance:
1D-4.99%
1M-2.77%
6M+1.06%
1Y-22.73%
5Y0.00%
View Company Insightsright
More news about Genomic Valley Biotech
15Jan 26
Genomic Valley Biotech Reports Q3FY26 Results with ₹1.05 Lakh Profit; Director Steps Down
Genomic Valley Biotech Limited announced its Q3FY26 financial results showing revenue of ₹5.00 lakh and net profit of ₹1.05 lakh, representing significant declines of 77.30% and 93.20% respectively compared to the previous year. The nine-month performance also showed similar downward trends with total revenue falling to ₹23.00 lakh from ₹58.81 lakh in the corresponding previous period. Additionally, the company announced the cessation of Mr. Ashok Kumar as Director due to non-completion of KYC requirements under the Companies Act.
 no imag found
07Aug 25
Genomic Valley Biotech Reports Q1 FY26 Results, Announces Key Appointments
Genomic Valley Biotech Limited (GVBL) released Q1 FY26 results, showing a 31.56% decrease in revenue to Rs. 6,16,000 and an 80.67% drop in net profit to Rs. 2,46,531 compared to Q1 FY25. The company appointed M/s. SBR & Co. LLP as Secretarial Auditors for 2025-2030, Mr. Navjyoti Kumar Jha as Internal Auditor for FY 2025-26, and re-appointed Mr. Yogesh Agrawal as Chairman & Managing Director for five years from September 7, 2025.
 no imag found
Genomic Valley Biotech
28.73
-1.51
(-4.99%)
1 Year Returns:-22.73%
Industry Peers
Anthem Biosciences
928.50
(+0.12%)
Advanced Enzyme Tech
287.80
(-0.10%)
CCME Global
36.45
(+4.98%)
Vivo Bio Tech
16.77
(-0.47%)